1-4 of 4
Sucheol Gil
Close
Sort by
Journal Articles

In vivo HSC transduction in rhesus macaques with an HDAd5/3 + vector targeting desmoglein 2 and transiently overexpressing cxcr4

Hongjie Wang, Audrey Germond, Chang Li, Sucheol Gil, Jiho Kim, Hans-Peter Kiem, André Lieber
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4360–4372.
https://doi.org/10.1182/bloodadvances.2022007975
Published: 2022
Includes: Supplemental data
Journal Articles

Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice

Chang Li, Kevin A. Goncalves, Tamás Raskó, Amit Pande, Sucheol Gil, Zhinan Liu, Zsuzsanna Izsvák, Thalia Papayannopoulou, John C. Davis, Jr, Hans-Peter Kiem, André Lieber
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1239–1249.
https://doi.org/10.1182/bloodadvances.2020003714
Published: 2021
Includes: Supplemental data
Journal Articles

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice

Chang Li, Aphrodite Georgakopoulou, Arpit Mishra, Sucheol Gil, R. David Hawkins, Evangelia Yannaki, André Lieber
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1122–1135.
https://doi.org/10.1182/bloodadvances.2020003702
Published: 2021
Includes: Supplemental data
Journal Articles

High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells

Hongjie Wang, Zhinan Liu, Chang Li, Sucheol Gil, Thalia Papayannopoulou, Christopher B. Doering, André Lieber
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2883–2894.
https://doi.org/10.1182/bloodadvances.2019000706
Published: 2019
Includes: Supplemental data